Clinical Trials
2 trialsNCT00004409 2015-03-25
Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00014742 2015-03-25
Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease
FDA Office of Orphan Products Development
Phase 3 Completed